Pharma and Diagnostics Competitive Intelligence: How to Anticipate Future Competitive intelligence (CI) is a commonly used decision-making tool in the pharmaceutical industry for seeking competitive advantage. It is often forward-looking…
How to Accurately Assess the True Addressable Market in Healthcare and Life Sciences Due Diligence Determining the appropriate addressable market is often one of the critical success factors in commercial…
How to Address Terminal Value Challenges in Pharmaceutical Asset Valuation Several stakeholders who have an interest in pharmaceutical assets employ a multitude of methods to conduct valuations. Among various valuation…
Win-win Investment Opportunities in Digital Health and IoT for Life Sciences Investors and Pharma Industry Digital Health and IoT are attractive opportunities for Life Sciences Investors and Pharmaceutical companies. The…
A deep understanding of the key biotechnology valuation drivers is critical for those who have an interest in biotech assets and businesses- read how to conduct pharma and biotech valuation…
A Value-Driven Commercialization Strategy for Pharmaceutical Assets An optimal commercialization strategy for pharmaceutical and biotechnology companies is vital for the value maximization of the company. Early-stage, as well as developed…
Effective Competitive Intelligence Strategies for Gaining an Edge in the Medical Devices Industry Medical devices are an important part of the healthcare industry, with tremendous potential to improve patient outcomes…
Key Success Factors for Effective Pharmaceutical Due Diligence and Risk Mitigation Due diligence is defined as the process by which buyers conduct the evaluation of investment opportunities. Several factors are…
Leveraging Path-to-Market Competitive Intelligence for Pharma Commercialization and Competitive Advantage Pharmaceutical Path-to-Market Competitive Intelligence is insights collection and generation across an asset's journey towards markets. Competitive Intelligence (CI) is a…